Literature DB >> 3103528

The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography.

H T Chugani, J C Mazziotta, J Engel, M E Phelps.   

Abstract

We employed positron emission tomography (PET) with 2-deoxy-2[18F]fluoro-D-glucose (FDG) to study local cerebral glucose utilization in 15 children who had Lennox-Gastaut syndrome. Our results show that LGS can be classified into four predominant subtypes, each with a distinct metabolic pattern: unilateral focal hypometabolism, unilateral diffuse hypometabolism, bilateral diffuse hypometabolism, and normal. Functional disturbances seen on FDG-PET did not always correlate with abnormalities revealed by x-ray computed tomographic scan. This classification of Lennox-Gastaut syndrome into four major metabolic subtypes not only provides a new perspective toward understanding cerebral function in this complex syndrome, but may also prove useful in the clinical management of these patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103528     DOI: 10.1002/ana.410210104

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

Review 1.  Positron emission tomography and the central nervous system.

Authors:  R O Robinson; C D Ferrie; M Capra; M N Maisey
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

2.  Long-term outcome in children with intractable epilepsy showing bilateral diffuse cortical glucose hypometabolism pattern on positron emission tomography.

Authors:  Varun Shandal; Amy L Veenstra; Michael Behen; Senthil Sundaram; Harry Chugani
Journal:  J Child Neurol       Date:  2011-09-22       Impact factor: 1.987

Review 3.  Neuroimaging of epilepsy.

Authors:  Fernando Cendes; William H Theodore; Benjamin H Brinkmann; Vlastimil Sulc; Gregory D Cascino
Journal:  Handb Clin Neurol       Date:  2016

4.  Resting-state activity in development and maintenance of normal brain function.

Authors:  Carolyn E Pizoli; Manish N Shah; Abraham Z Snyder; Joshua S Shimony; David D Limbrick; Marcus E Raichle; Bradley L Schlaggar; Matthew D Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

5.  Focal abnormalities detected by 18FDG PET in epileptic encephalopathies.

Authors:  C D Ferrie; M Maisey; T Cox; C Polkey; S F Barrington; C P Panayiotopoulos; R O Robinson
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791

6.  Cortical and subcortical glucose metabolism in childhood epileptic encephalopathies.

Authors:  C D Ferrie; P K Marsden; M N Maisey; R O Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

7.  Single photon emission computed tomography in seizure disorders.

Authors:  R Denays; M Rubinstein; H Ham; A Piepsz; P Noël
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

8.  Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography.

Authors:  K Yanai; K Iinuma; T Matsuzawa; M Ito; S Miyabayashi; K Narisawa; T Ido; K Yamada; K Tada
Journal:  Eur J Nucl Med       Date:  1987

9.  Neuroimaging and spectroscopy in children with epileptic encephalopathies.

Authors:  A P Parker; C D Ferrie; S Keevil; M Newbold; T Cox; M Maisey; R O Robinson
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

10.  Increased interictal cerebral glucose metabolism in a cortical-subcortical network in drug naive patients with cryptogenic temporal lobe epilepsy.

Authors:  M Franceschi; G Lucignani; A Del Sole; C Grana; S Bressi; F Minicucci; C Messa; M P Canevini; F Fazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.